GlassScriptPhysician profile
Nicholas Dyson Casscells
NPI 1811330996
$3,611.07
in general payments reported to CMS, 2019-2025
13 companies · $1,572 in 2025
The $1,572 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $309 · 2021: $336 · 2022: $236 · 2023: $604 · 2024: $240 · 2025: $1,572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,421 · Travel and Lodging: $995.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,421.49 |
| Travel and Lodging | $994.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,390.91 | 2019-2025 | Augment Injectable, Ortholoc 3di, Prostep Mica |
| Vericel Corporation | $994.88 | 2025 | Maci |
| Paragon 28, INC. | $278.94 | 2019-2020 | |
| Si-Bone, INC. | $145.50 | 2020 | |
| Medline Industries LP | $142.87 | 2024 | |
| Smith+Nephew, INC. | $140.38 | 2025 | Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Zimmer Biomet Holdings, INC. | $125.38 | 2023 | Affixus |
| Supreme Orthopedic Systems, LLC | $115.54 | 2025 | |
| Linvatec Corporation | $109.81 | 2023 | Allograft Tissue |
| Ossio INC | $74.94 | 2021 | |
| Ortho Solutions INC | $59.39 | 2019 | |
| Arteriocyte Medical Systems, INC. | $17.61 | 2021 | |
| Depuy Synthes Sales INC. | $14.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Casscells listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.